Company Overview
Snapshot
Founded in December 2021 by Olga Nissan, Protica Bio operates with 1-10 employees. The company has secured funding across one round from one investor. In July 2022, Protica Bio received funding from VLX Ventures.
Business overview
Protica Bio develops an immunotherapy-based diagnostics platform that leverages proteomics and machine learning to enhance clinical decisions and accelerate new drug discoveries. The company aims to improve the response rate for current and future treatments by integrating deep proteomics with machine learning. Utilizing a proprietary platform developed by an expert in mass spectrometry from the Weizmann Institute, Protica Bio serves the healthcare and life sciences sectors, specifically targeting laboratories within the Health Tech & Life Sciences industry.
Log in to access full profile ›Company Intelligence Q&A
- When was Protica Bio founded?
- Protica Bio was founded in December 2021.
- Who is the founder of Protica Bio?
- Olga Nissan is the founder of Protica Bio.
- What is Protica Bio's primary sector?
- Protica Bio's primary sector is Health Tech & Life Sciences.
- How many employees does Protica Bio have?
- Protica Bio has 1-10 employees.
- What is Protica Bio's core technology?
- Protica Bio's core technology includes platforms & interfaces, specifically web, and artificial intelligence, specifically machine learning.